» Articles » PMID: 33105086

Reply to Weatherald : Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce De Résistance?

Overview
Specialty Critical Care
Date 2020 Oct 26
PMID 33105086
Authors
Affiliations
Soon will be listed here.
References
1.
Tello K, Richter M, Yogeswaran A, Ghofrani H, Naeije R, Vanderpool R . Sex Differences in Right Ventricular-Pulmonary Arterial Coupling in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2020; 202(7):1042-1046. PMC: 7528786. DOI: 10.1164/rccm.202003-0807LE. View

2.
Badagliacca R, Papa S, Manzi G, Miotti C, Luongo F, Sciomer S . Usefulness of Adding Echocardiography of the Right Heart to Risk-Assessment Scores in Prostanoid-Treated Pulmonary Arterial Hypertension. JACC Cardiovasc Imaging. 2020; 13(9):2054-2056. DOI: 10.1016/j.jcmg.2020.04.005. View

3.
Badagliacca R, DAlto M, Ghio S, Argiento P, Bellomo V, Brunetti N . Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2020; 203(4):484-492. DOI: 10.1164/rccm.202004-1006OC. View

4.
Badagliacca R, Papa S, Matsubara H, Lang I, Poscia R, Manzi G . The importance of right ventricular evaluation in risk assessment and therapeutic strategies: Raising the bar in pulmonary arterial hypertension. Int J Cardiol. 2019; 301:183-189. DOI: 10.1016/j.ijcard.2019.10.043. View

5.
van de Veerdonk M, Kind T, Marcus J, Mauritz G, Heymans M, Bogaard H . Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol. 2011; 58(24):2511-9. DOI: 10.1016/j.jacc.2011.06.068. View